National Comprehensive Cancer Network

NCCN Global Academy for Excellence & Leadership in Oncology™: School of Pharmaceutical & Biotech Business will take place on the 26 September at the Hotel Miramar Barcelona in Barcelona, Spain.

During this program, pharmaceutical and biotechnology professionals will be given the rare opportunity to view the global oncology space, its future and its current operational issues from the provider, payer, and patient advocate perspective. Participants will improve their working knowledge of key global business, policy, informational, and operational issues in oncology and will gather valuable insights to develop effective strategies for navigating worldwide cancer care issues. Through this interactive program, pharmaceutical and biotech professionals will learn from key stakeholders what they view to be the most pressing issues in the global oncology environment and how to apply this knowledge to create mutually successful working relationships.

Professionals from marketing, sales, advocacy, medical affairs, clinical research, international programs, policy and government affairs, and other business areas will better be able to serve their customers with improved knowledge of real-world oncology issues after completion of this program.

Please check back often for additional updates regarding this program. If you have any questions, please contact Caitlin Donnelly, Senior Global Business Development Specialist.

CURRICULUM*

12:00 – 12:45 PM	Lunch
12:45 – 12:50 PM	Welcome Caitlin Donnelly Senior Global Business Development Specialist National Comprehensive Cancer Network
12:50 – 1:05 PM	Presentation: Introduction to Global Initiatives C. Lyn Fitzgerald, MJ Senior Vice President, U.S. & Global Development National Comprehensive Cancer Network
1:10 – 2:50 PM	Module I: Global Resources - Meet NCCN Guidelines® Panel and Collaborative Experts Moderator: Wui-Jin Koh, MD Senior Vice President/Chief Medical Officer National Comprehensive Cancer Network Panelists: Abubakar M. Bello, MD Consultant in Clinical Oncology and Head of Department National Hospital Abuja Al B. Benson III, MD, FACP, FASCO/Chair Professor of Medicine Associate Director for Cooperative Groups Chair, NCCN Guidelines for Colon/Rectal/Anal and Hepatobiliary Cancers Panels Member, NCCN Guidelines for Neuroendocrine and Adrenal Tumors and Pancreatic Adenocarcinoma Board Member, National Comprehensive Cancer Network Board Member, NCCN Foundation Robert H. Lurie Comprehensive Cancer Center of Northwestern University David S. Ettinger, MD/Chair Professor of Oncology Chair, NCCN Guidelines for Non-Small Cell Lung Cancer, MPM, Thymomas Panels Member, NCCN Guidelines for Antiemesis and Lung Cancer Screening Panels Chair, Guideline Steering Committee The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Prof. Jesus Garcia-Foncillas, MD, PhD Professor, School of Medicine Director, Professorship on Molecular Individualized Medicine, Autonomous University of Madrid-Merck Director, OncoHealth Institute Director, Department of Oncology Director, Translational Oncology Division, Research Institute FJD-UAM University Hospital "Fundacion Jimenez Diaz" Autonomous University of Madrid Steven J. Schuetz, MD Founder, PROMIS-Bolivia S.A. General Surgery Resident (PGY-6), Department of Surgery Northwestern University, Feinberg School of Medicine Lalan Wilfong, MD Vice President Quality Programs Texas Oncology
2:50 – 3:05 PM	Break
3:10 - 3:35 PM	NAVIFY™ Clinical Decision Support and the Use of the NCCN Guidelines at Point of Care Laurence J Heifetz, MD, FACP Founder Gene Upshaw Memorial Tahoe Forest Cancer Center Clinical Professor of Medicine UC Davis School of Medicine Advisory Board Member Roche Diagnostics Information Systems
3:40 – 5:20 PM	Module II: Initiatives and Best Practices for Adoption of Guidelines to Ensure Access to High Quality Care Moderator C. Lyn Fitzgerald, MJ Senior Vice President, U.S. & Global Development National Comprehensive Cancer Network Panelists: Ignacio Durán, MD, PhD NCCN Guidelines for Prostate Cancer Collaborative International Expert Medical Oncology Department Hospital Universitario Marques de Valdecilla. IDIVAL. Santander. Spain Laurence J Heifetz, MD, FACP Founder Gene Upshaw Memorial Tahoe Forest Cancer Center Clinical Professor of Medicine UC Davis School of Medicine Advisory Board Member Roche Diagnostics Information Systems Juan-Carlos Jaramillo, MD Senior Vice President - Head of Global Market Access & Pricing Daiichi Sankyo Francois Maignen Principle Technical Advisor NICE Scientific Advice Agata Polińska Vice president, Member of the Management Board ALIVIA - FUNDACJA ONKOLOGICZNA Lalan Wilfong, MD Vice President Quality Programs Texas Oncology
5:25 – 5:30 PM	Closing Remarks Gary Weyhmuller, MBA, SPHR Executive Vice President/Chief Operating Officer National Comprehensive Cancer Network

*Curriculum subject to change.

LOCATION

Hotel Miramar Barcelona
Placa de Carlos Ibanez, 3, 08038
Barcelona, Spain

Customize your own NCCN Academy curriculum.

NCCN offers the unique opportunity to customize an NCCN Academy curriculum that best aligns with your organization's particular needs and interests.

Approximately 97 percent of recent NCCN Academy attendees say they would attend an NCCN Academy program again or recommend that colleagues attend.